Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program

Detalhes bibliográficos
Autor(a) principal: Rodrigues, Ana Laura Pereira
Data de Publicação: 2000
Outros Autores: Almeida, Andrey Peterson de, Rodrigues, Bethânia de Freitas, Pinheiro, Carla Aparecida, Borges, Daniela Santos, Mendonça, Marcelo Luiz Holanda de, Silva, Vinícius Eustáquio Ferreira da, Goulart, Isabela Maria Remarries
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Hansenologia Internationalis (Online)
Texto Completo: https://periodicos.saude.sp.gov.br/hansenologia/article/view/35370
Resumo: Leprosy would be an ordinary disease; however, it is not due to its reactive episodes with risk of disability maintaining the stigma related to the leprosy. These reactions and the potential loss of the neural function may happen before, during and after treatment, through a multidrug therapy (MDT). Release from treatment results from the number of doses and regularity of the treatment, when the patient leaves the coefficientsof prevalence. The aim was to evaluate the magnitude of late leprosy reactions and the operational subjects referring to the attendance quality. Charts of the 149 patients that received discharge for leprosy from 1994 to 1999, in CSE Jaraguá - UFU, Brazil, were revised using the Record of Inquiry of Alterations After Cure of the Brazilian Ministry of Health. Of these patients, 34 (23%) presented late reaction, of which 11,76% were paucibacillary (PB) and 88,23% were multibacillary (MB). An average of 3 reactive episodes for borderline patient and 4 episodes for lepromatous patient occurred. Of PB patients, 100% presented reversal reaction (RR). Among MB, 50% presented RR, 40% erythema nodosum leprosum (ENL), 7% isolated neuritis and 3% mixed reaction. In 91% of the cases, the first reactive episode happened in the first year after treatment.There was a positive correlation among medium bacillary index (BI) at diagnosis and the number of reaction episodes during treatment and after release. Among patients with late reaction, 97% used prednisone and 32% thalidomide,meaning 22% and 8% from the total, respectively. Grade of disability 2 and 3 happened in MB patients of the economically active age. It is discussed the need of implementing leprosy control programs for that new group of patients with warranty of treatment, personnel training for simplified monitoring of neuritis and handling of the adverse effects of corticosteroids therapeutics, seeking the prevention of disabilities.
id ILSL-1_428dd6faa58d8bd7d183a501ec1a3002
oai_identifier_str oai:ojs.periodicos.saude.sp.gov.br:article/35370
network_acronym_str ILSL-1
network_name_str Hansenologia Internationalis (Online)
repository_id_str
spelling Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care programOcorrência de reações em pacientes pós-alta por cura de hanseníase: subsídios para implementação de um programa de atenção específicaHanseníaseReações hansênicasProgramas de controlePrevenção de incapacidadesLeprosyLeprosy ReactionLeprosy control programsPrevention of DisabilitiesLeprosy would be an ordinary disease; however, it is not due to its reactive episodes with risk of disability maintaining the stigma related to the leprosy. These reactions and the potential loss of the neural function may happen before, during and after treatment, through a multidrug therapy (MDT). Release from treatment results from the number of doses and regularity of the treatment, when the patient leaves the coefficientsof prevalence. The aim was to evaluate the magnitude of late leprosy reactions and the operational subjects referring to the attendance quality. Charts of the 149 patients that received discharge for leprosy from 1994 to 1999, in CSE Jaraguá - UFU, Brazil, were revised using the Record of Inquiry of Alterations After Cure of the Brazilian Ministry of Health. Of these patients, 34 (23%) presented late reaction, of which 11,76% were paucibacillary (PB) and 88,23% were multibacillary (MB). An average of 3 reactive episodes for borderline patient and 4 episodes for lepromatous patient occurred. Of PB patients, 100% presented reversal reaction (RR). Among MB, 50% presented RR, 40% erythema nodosum leprosum (ENL), 7% isolated neuritis and 3% mixed reaction. In 91% of the cases, the first reactive episode happened in the first year after treatment.There was a positive correlation among medium bacillary index (BI) at diagnosis and the number of reaction episodes during treatment and after release. Among patients with late reaction, 97% used prednisone and 32% thalidomide,meaning 22% and 8% from the total, respectively. Grade of disability 2 and 3 happened in MB patients of the economically active age. It is discussed the need of implementing leprosy control programs for that new group of patients with warranty of treatment, personnel training for simplified monitoring of neuritis and handling of the adverse effects of corticosteroids therapeutics, seeking the prevention of disabilities.A hanseníase seria uma doença comum se não fosse por seus episódios reacionais com risco de incapacidades mantendo o estigma relacionado à "lepra". Essas reações e a perda potencial da função neural podem ocorrer antes, durante e após o tratamento, feito com poliquimioterapia (PQT). A alta por cura se dá pelo número de doses e regularidade do tratamento, quando o paciente sai do registro ativo e dos coeficientes de prevalência. Objetivando avaliar a magnitude das reações hansênicas pós-alta e as questões operacionais referentes a qualidade da assistência, foram revisados prontuários de 149 pacientes quereceberam alta de hanseníase de 1994 a 1999, no Centro de Saúde Escola Jaraguá — UFU, utilizando a Ficha de Investigação de Intercorrências Pós-Alta por Cura do Ministério da Saúde. Destes, 34 (23%) apresentaram reação pós-alta, sendo 11,76% PB e 88,23% MB. Ocorreu uma média de 3 episódios por paciente dimorfo e 4 por paciente virchowiano. Dos PB, 100% apresentaram reação reversa (RR). Entre os MB, 50% apresentaram RR, 40% eritema nodoso hansênico (ENH), 7% neurite isolada e 3% reação mista. Em 91% dos casos, o primeiro episódio reacional ocorreu no primeiro ano pós-tratamento. Houve correlação positiva entre IB médio no diagnóstico e número deepisódios reacionais durante o tratamento e pós-alta. Dos pacientes com reação pós-alta, 97% utilizaram prednisona e 32% talidomida, significando 22% e 8%, respectivamente,dos pacientes em alta. Graus de incapacidade II e Ill ocorreram em MB da faixa etária economicamente ativa.Discute-se a necessidade de implementar programas de controle específicos para esse novo grupo de pacientes, com garantia de medicamentos, capacitação de pessoal para o monitoramento simplificado das neurites e o manejo dos efeitos adversos da terapêutica com corticoesteróides, visando à prevenção de incapacidades.Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo2000-06-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAvaliado pelos paresapplication/pdfapplication/pdfhttps://periodicos.saude.sp.gov.br/hansenologia/article/view/3537010.47878/hi.2000.v25.35370Hansenologia Internationalis: leprosy and other infectious diseases; Vol. 25 No. 1 (2000); 7-16Hansenologia Internationalis: hanseníase e outras doenças infecciosas; v. 25 n. 1 (2000); 7-161982-5161reponame:Hansenologia Internationalis (Online)instname:Instituto Lauro de Souza Lima (ILSL)instacron:ILSLporenghttps://periodicos.saude.sp.gov.br/hansenologia/article/view/35370/33802https://periodicos.saude.sp.gov.br/hansenologia/article/view/35370/33803https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRodrigues, Ana Laura PereiraAlmeida, Andrey Peterson deRodrigues, Bethânia de FreitasPinheiro, Carla AparecidaBorges, Daniela SantosMendonça, Marcelo Luiz Holanda deSilva, Vinícius Eustáquio Ferreira daGoulart, Isabela Maria Remarries2023-09-27T14:00:41Zoai:ojs.periodicos.saude.sp.gov.br:article/35370Revistahttps://periodicos.saude.sp.gov.br/hansenologiaPRIhttps://periodicos.saude.sp.gov.br/hansenologia/oaihansen_int@ilsl.br || hansenologia.internationalis@gmail.com || periodicossp@saude.sp.gov.br1982-51610100-3283opendoar:2023-09-27T14:00:41Hansenologia Internationalis (Online) - Instituto Lauro de Souza Lima (ILSL)false
dc.title.none.fl_str_mv Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program
Ocorrência de reações em pacientes pós-alta por cura de hanseníase: subsídios para implementação de um programa de atenção específica
title Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program
spellingShingle Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program
Rodrigues, Ana Laura Pereira
Hanseníase
Reações hansênicas
Programas de controle
Prevenção de incapacidades
Leprosy
Leprosy Reaction
Leprosy control programs
Prevention of Disabilities
title_short Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program
title_full Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program
title_fullStr Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program
title_full_unstemmed Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program
title_sort Occurrence of late lepra reaction in leprosy pacients: subsidies for implementation of a specific care program
author Rodrigues, Ana Laura Pereira
author_facet Rodrigues, Ana Laura Pereira
Almeida, Andrey Peterson de
Rodrigues, Bethânia de Freitas
Pinheiro, Carla Aparecida
Borges, Daniela Santos
Mendonça, Marcelo Luiz Holanda de
Silva, Vinícius Eustáquio Ferreira da
Goulart, Isabela Maria Remarries
author_role author
author2 Almeida, Andrey Peterson de
Rodrigues, Bethânia de Freitas
Pinheiro, Carla Aparecida
Borges, Daniela Santos
Mendonça, Marcelo Luiz Holanda de
Silva, Vinícius Eustáquio Ferreira da
Goulart, Isabela Maria Remarries
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Rodrigues, Ana Laura Pereira
Almeida, Andrey Peterson de
Rodrigues, Bethânia de Freitas
Pinheiro, Carla Aparecida
Borges, Daniela Santos
Mendonça, Marcelo Luiz Holanda de
Silva, Vinícius Eustáquio Ferreira da
Goulart, Isabela Maria Remarries
dc.subject.por.fl_str_mv Hanseníase
Reações hansênicas
Programas de controle
Prevenção de incapacidades
Leprosy
Leprosy Reaction
Leprosy control programs
Prevention of Disabilities
topic Hanseníase
Reações hansênicas
Programas de controle
Prevenção de incapacidades
Leprosy
Leprosy Reaction
Leprosy control programs
Prevention of Disabilities
description Leprosy would be an ordinary disease; however, it is not due to its reactive episodes with risk of disability maintaining the stigma related to the leprosy. These reactions and the potential loss of the neural function may happen before, during and after treatment, through a multidrug therapy (MDT). Release from treatment results from the number of doses and regularity of the treatment, when the patient leaves the coefficientsof prevalence. The aim was to evaluate the magnitude of late leprosy reactions and the operational subjects referring to the attendance quality. Charts of the 149 patients that received discharge for leprosy from 1994 to 1999, in CSE Jaraguá - UFU, Brazil, were revised using the Record of Inquiry of Alterations After Cure of the Brazilian Ministry of Health. Of these patients, 34 (23%) presented late reaction, of which 11,76% were paucibacillary (PB) and 88,23% were multibacillary (MB). An average of 3 reactive episodes for borderline patient and 4 episodes for lepromatous patient occurred. Of PB patients, 100% presented reversal reaction (RR). Among MB, 50% presented RR, 40% erythema nodosum leprosum (ENL), 7% isolated neuritis and 3% mixed reaction. In 91% of the cases, the first reactive episode happened in the first year after treatment.There was a positive correlation among medium bacillary index (BI) at diagnosis and the number of reaction episodes during treatment and after release. Among patients with late reaction, 97% used prednisone and 32% thalidomide,meaning 22% and 8% from the total, respectively. Grade of disability 2 and 3 happened in MB patients of the economically active age. It is discussed the need of implementing leprosy control programs for that new group of patients with warranty of treatment, personnel training for simplified monitoring of neuritis and handling of the adverse effects of corticosteroids therapeutics, seeking the prevention of disabilities.
publishDate 2000
dc.date.none.fl_str_mv 2000-06-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicos.saude.sp.gov.br/hansenologia/article/view/35370
10.47878/hi.2000.v25.35370
url https://periodicos.saude.sp.gov.br/hansenologia/article/view/35370
identifier_str_mv 10.47878/hi.2000.v25.35370
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://periodicos.saude.sp.gov.br/hansenologia/article/view/35370/33802
https://periodicos.saude.sp.gov.br/hansenologia/article/view/35370/33803
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo
publisher.none.fl_str_mv Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo
dc.source.none.fl_str_mv Hansenologia Internationalis: leprosy and other infectious diseases; Vol. 25 No. 1 (2000); 7-16
Hansenologia Internationalis: hanseníase e outras doenças infecciosas; v. 25 n. 1 (2000); 7-16
1982-5161
reponame:Hansenologia Internationalis (Online)
instname:Instituto Lauro de Souza Lima (ILSL)
instacron:ILSL
instname_str Instituto Lauro de Souza Lima (ILSL)
instacron_str ILSL
institution ILSL
reponame_str Hansenologia Internationalis (Online)
collection Hansenologia Internationalis (Online)
repository.name.fl_str_mv Hansenologia Internationalis (Online) - Instituto Lauro de Souza Lima (ILSL)
repository.mail.fl_str_mv hansen_int@ilsl.br || hansenologia.internationalis@gmail.com || periodicossp@saude.sp.gov.br
_version_ 1796797579302797312